Additional Information
| Size: | 100 µg | 
| Target: | WIPI2 | 
| Conjugate: | FITC | 
| Research Area: | Cancer | Autophagy | 
| Alternative Name: | WIPI2 Antibody, WD repeat domain phosphoinositide-interacting protein 2 Antibody, WIPI-2 Antibody, WIPI49-like protein 2 Antibody, CGI-50 Antibody, ATG21 Antibody, WIPI 2 Antibody, ATG18B Antibody | 
| Category: | Antibodies | 
| Product Type: | Polyclonal Antibody | 
| Immunogen: | Synthetic peptide from the C-terminal of Human WIPI2 | 
| Immunogen Species: | Human | 
| Applications: | WB, ICC/IF, IHC | 
| Host: | Rabbit | 
| Isotype: | N/A | 
| Species Reactivity: | Human | 
| Antibody Dilution: | WB (1:1000), ICC/IF (1:100); IHC (1:50); optimal dilutions for assays should be determined by the user. | 
| Purification: | Peptide Affinity Purified | 
| Storage Buffer: | PBS, 50% glycerol, 0.09% sodium azide | 
| Concentration: | 1 mg/ml | 
| Specificity: | Detects ~55 kDa. | 
| Storage: | -20ºC | 
| Shipping: | Blue Ice or 4ºC | 
| Certificate of Analysis: | A 1:1000 dilution of SPC-649 was sufficient for detection of WIPI2 in 15 µg of human HeLa cell lysates by ECL immunoblot analysis using goat anti-rabbit IgG:HRP as the secondary antibody. | 
| Cellular Localization: | Preautophagosomal Structure Membrane, Peripheral Membrane Protein, Cytoplasmic Side | 
| Tissue Specificity: | Ubiquitously expressed (at protein level). Highly expressed in heart, skeletal muscle and pancreas. Expression is down-regulated in pancreatic and in kidney tumors. | 
| Accession Number: | NP_001028690.1 | 
| Gene ID: | 26100 | 
| Swiss-Prot: | Q9Y4P8 | 
| Field of Use: | For in vitro research use only. | 
 
             
             
             
             
             
             
             
             
             
            